Essential Science

Fleet Bioprocessing Ltd. and Essential Science Ltd. today announced the establishment of a collaboration focused on the development and commercialisation of Fleet’s protein conjugation technologies within the European Life Science marketplace. The collaboration will accelerate Fleet’s growth providing the pharmaceutical industry with the service necessary to access Fleet’s technologies rapidly and efficiently.

Fleet are internationally recognised experts in the field of protein conjugation. Their extensive experience in all aspects of conjugate development and manufacture positions them as the leading source of expertise in this fast-growing product sector.

Commenting on the agreement, Alastair Dent, MD of Fleet Bioprocessing said, “We are delighted to have finalised this arrangement with Essential Science. Conjugated protein therapeutics are increasingly being recognised for their impressive in vivo capabilities, and we believe our expertise in conjugation chemistry offers the opportunity for developers to arrive more rapidly at better product designs. Good drugs of this type are undoubtedly lying undiscovered due to the current lack of conjugation expertise in the sector. Essential Science is ideally positioned to help us develop our services in the pharmaceutical market.”

Neil Murray, Director of Essential Science said, “We are very pleased that we have been able to add Fleet to our portfolio of biologic technology clients. We believe that, in addition to the exceptional capabilities that Fleet have in the area of protein conjugation, they provide a strongly complimentary capability in the development of protein therapeutics. Essential Science’s innovative business model significantly shortens commercial development times for technology companies. Our continued focus on providing technology users with access to those technologies that can make a difference to their every-day business will allow us to generate substantial market-share for Fleet’s protein conjugation technologies.”

About Fleet Bioprocessing

Fleet Bioprocessing offers a range of reagent development, validation and manufacturing services within the Life Science marketplace, with key expertise in protein conjugation and purification techniques. Fleet operates to the most demanding quality standards while maintaining a rapid delivery record and places a high level of emphasis on communication to ensure that client needs are fully understood. Based in Hampshire, United Kingdom, Fleet Bioprocessing was founded in 2000.

Enquiries :: Alistair Dent :: +44 1252 614477 :: al@fleetbioprocessing.co.uk

About Essential Science

Essential Science understands client business across the Life Science marketplace. Our staff and associates are experts on biotechnology, pharmaceuticals, fine chemicals and diagnostics. We support technology exploitation between business partners and work with Technology Providers and Users, to help bridge their technology gaps and bring client technologies to market faster and more effectively. Essential Science is headquartered in Glasgow, United Kingdom and was founded in 2003.

Enquiries :: Neil Murray :: +44 1356 648941 :: neil@essentialscience.co.uk

Date :: 3rd March 2005